SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Gold/Mining/Energy : Response Biomedical (V.RBM) -- Ignore unavailable to you. Want to Upgrade?

To: gg cox who wrote (614)1/6/2007 10:36:37 PM
From: Dick Martin  Read Replies (1) | Respond to of 655
 
It isn't clear how this relates to RBM other than to suggest that RAMP could test for any of the cancer biomarkers. The Ramp reader is platform that can test for almost any marker. The opportunity here is huge but the year ahead will be significant in terms of cardiac test coming to market as well as infectious disease test being developed with 3M. We will just have to see where management want to go from there.

Dick


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News